login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
MERCK & CO. INC. (MRK) Stock News
USA
- NYSE:MRK -
US58933Y1055
-
Common Stock
85.7
USD
-0.29 (-0.34%)
Last: 10/13/2025, 7:13:40 PM
85.6875
USD
-0.01 (-0.01%)
After Hours:
10/13/2025, 7:13:40 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MRK Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
- Mentions:
PFEB
NKE
LLY
NFLX
...
Wall Street Holds Firm Despite Shutdown and Weak Jobs Data
12 days ago - By: Chartmill
- Mentions:
BIIB
CRL
REGN
LLY
...
Wednesday's session: top gainers and losers in the S&P500 index
4 hours ago - By: Zacks Investment Research
- Mentions:
AAPL
LLY
V
ADP
...
Top Stock Reports for Apple, Eli Lilly & Visa
8 hours ago - By: Zacks Investment Research
Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?
10 hours ago - By: Zacks Investment Research
Here's Why Merck (MRK) is a Strong Momentum Stock
10 hours ago - By: Benzinga
- Mentions:
AGX
ADPT
EGP
GM
...
Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday
14 hours ago - By: The Motley Fool
- Mentions:
PPH
PFE
JNJ
NVO
...
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?
3 days ago - By: Zacks Investment Research
- Mentions:
AZN
BMY
Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?
4 days ago - By: Benzinga
Behind the Scenes of Merck & Co's Latest Options Trends
5 days ago - By: Merck & Co., Inc.
Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025
5 days ago - By: Merck Sharp & Dohme
Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
5 days ago - By: Bragar Eagel & Squire
MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
6 days ago - By: Investor's Business Daily
- Mentions:
RCUS
How Arcus Biosciences Aims To Take On Merck In Cancer Treatment
7 days ago - By: Merck & Co., Inc.
- Mentions:
VRNA
Merck Completes Acquisition of Verona Pharma
8 days ago - By: Merck Sharp & Dohme
Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases
8 days ago - By: The Motley Fool
- Mentions:
SMMT
1 Monster Stock in the Making to Buy and Hold
11 days ago - By: Zacks Investment Research
- Mentions:
BMY
NVO
Can Novo Nordisk's Restructuring Program Drive its Return to Growth?
11 days ago - By: Zacks Investment Research
- Mentions:
PFE
MRNA
BNTX
Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency?
11 days ago - By: Zacks Investment Research
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?
11 days ago - By: Zacks Investment Research
Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?
12 days ago - By: Chartmill
- Mentions:
DHR
NKE
BMY
PFE
...
In today's session, there are S&P500 stocks with remarkable trading volume.
12 days ago - By: Zacks Investment Research
- Mentions:
CORT
Can Relacorilant Drive Corcept's Long-Term Growth Beyond Korlym?
13 days ago - By: Merck & Co., Inc.
Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30
13 days ago - By: Chartmill
- Mentions:
FCX
ALB
DHR
BX
...
What's going on in today's session: S&P500 movers
13 days ago - By: Chartmill
- Mentions:
FCX
ALB
DHR
COF
...
Discover which S&P500 stocks are making waves on Tuesday.
19 days ago - By: Chartmill
Merck & Co. Inc. (NYSE:MRK): A Prime Candidate for a Dependable Dividend Portfolio
Please enable JavaScript to continue using this application.